Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | GRM8 | O00222 | 2/20 | 0.51 |
| ▸ | GRM6 | O15303 | 2/20 | 0.51 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.51 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.51 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.51 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.51 |
| ▸ | GRIA3 | P42263 | 2/20 | 0.51 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.51 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.51 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.51 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.51 |
| ▸ | GRM5 | P41594 | 1/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.51 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.51 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.51 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL4356748 | 1.00 | CYP1A2 (0.51) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL23306565 | 1.00 | CYP1A2 (0.51) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL19209941 | 1.00 | CYP1A2 (0.51) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL23291081 | 0.99 | CYP1A2 (0.50) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL5670423 | 0.95 | CYP1A2 (0.46) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL2730156 | 0.95 | ALOX15 (0.49) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL4229349 | 0.95 | CYP1A2 (0.46) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL2727906 | 0.95 | ALOX15 (0.49) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL9389369 | 0.95 | ALOX15 (0.49) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Histidine SCHEMBL17981689 | 0.95 | GRIA1 (0.46) | CYP1A2GRM8GRM6GRM7GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210991-A1 | ANTIBODY-CONTAINING FORMULATION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-07-06 | — | — | US | claimed |
| EP-4159236-A1 | ANTIBODY-CONTAINING FORMULATION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-04-05 | — | — | EP | claimed |
| US-11612562-B2 | Solution preparation containing stabilized antibody | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-03-28 | — | — | US | claimed |
| US-20230078678-A1 | FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF TREATING ATOPIC DERMATITIS | AMGEN INC. | 2023-03-16 | — | — | US | claimed |
| CN-115697404-A | Antibody-containing preparation | 中外制药株式会社 | 2023-02-03 | — | — | CN | claimed |
| EP-4103235-A1 | FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF TREATING INFLAMMATORY DISEASE | Amgen Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| CN-115279404-A | Formulation of human anti-TSLP antibodies and methods of treating inflammatory diseases | 安进公司 | 2022-11-01 | — | — | CN | claimed |
| US-20220192179-A1 | BIOMIMETIC ICE-INHIBITING MATERIAL AND CRYOPRESERVATION SOLUTION COMPRISING SAME | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-23 | — | — | US | claimed |
| WO-2021241720-A1 | ANTIBODY-CONTAINING FORMULATION | 中外製薬株式会社 | 2021-12-02 | — | — | WO | claimed |
| EP-3892292-A2 | STABILIZED ANTIBODY-CONTAINING LIQUID FORMULATIONS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2021-10-13 | — | — | EP | claimed |
| CN-102858366-A | Solution formulations containing stabilized antibodies | CHUGAI PHARMACEUTICAL CO LTD | 2013-01-02 | — | — | CN | claimed |
| EP-1805303-A2 | MUTANT POLYMERASES FOR SEQUENCING AND GENOTYPING | Li-Cor, Inc. (US) | 2007-07-11 | — | — | EP | claimed |
| US-20070048748-A1 | Mutant polymerases for sequencing and genotyping | LI-COR, INC. (US) | 2007-03-01 | — | — | US | claimed |
| WO-2006037064-A2 | MUTANT POLYMERASES FOR SEQUENCING AND GENOTYPING | LI-COR, INC. (US) | 2006-04-06 | — | — | WO | claimed |
| US-20020049301-A1 | Short peptides which selectively modulate the activity of serine/threonine kinases | THE CHILDREN'S MEDICAL CENTER CORP. (US) | 2002-04-25 | — | — | US | claimed |
| EP-0983346-A2 | SHORT PEPTIDES WHICH SELECTIVELY MODULATE THE ACTIVITY OF SERINE/THREONINE KINASES | The Children's Medical Center Corporation (US) | 2000-03-08 | — | — | EP | claimed |
| WO-1998053050-A2 | SHORT PEPTIDES WHICH SELECTIVELY MODULATE THE ACTIVITY OF SERINE/THREONINE KINASES | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1998-11-26 | — | — | WO | claimed |
| EP-0210257-A4 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS. | HURWITZ CHARLES (US) | 1988-01-20 | — | — | EP | claimed |
| EP-0210257-A1 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS | HURWITZ, Charles (US) | 1987-02-04 | — | — | EP | claimed |
| WO-1986004588-A1 | PROTEIN WHICH IS CHARACTERISTIC OF RHEUMATOID ARTHRITIS | HURWITZ CHARLES (US) | 1986-08-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230078678-A1 | FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF TREATING ATOPIC DERMATITIS | TSLP, IL5, ORAI1 | CYP1A2 4860/4885GRM8 2847/4885GRM6 1998/4885 |
| US-20220192179-A1 | BIOMIMETIC ICE-INHIBITING MATERIAL AND CRYOPRESERVATION SOLUTION COMPRISING SAME | IGFBP1, IGFBP2, BCL2L1 | CYP1A2 2702/4885GRM8 4667/4885GRM6 4738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.